The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad
Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2013-01-01
|
| Series: | Indian Journal of Medical and Paediatric Oncology |
| Subjects: | |
| Online Access: | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=189;epage=192;aulast=Shah |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849322690758836224 |
|---|---|
| author | Sandip A Shah |
| author_facet | Sandip A Shah |
| author_sort | Sandip A Shah |
| collection | DOAJ |
| description | Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%. |
| format | Article |
| id | doaj-art-43fdca026a69453497c7d48d76ead4d8 |
| institution | Kabale University |
| issn | 0971-5851 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
| record_format | Article |
| series | Indian Journal of Medical and Paediatric Oncology |
| spelling | doaj-art-43fdca026a69453497c7d48d76ead4d82025-08-20T03:49:17ZengThieme Medical and Scientific Publishers Pvt. Ltd.Indian Journal of Medical and Paediatric Oncology0971-58512013-01-0134318919210.4103/0971-5851.123729The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, AhmedabadSandip A ShahGujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=189;epage=192;aulast=ShahChronic myeloid leukemiaGujarat cancer and research instituteimatinib |
| spellingShingle | Sandip A Shah The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad Indian Journal of Medical and Paediatric Oncology Chronic myeloid leukemia Gujarat cancer and research institute imatinib |
| title | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_full | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_fullStr | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_full_unstemmed | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_short | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_sort | treatment of chronic myeloid leukemia data from gujarat cancer and research institute ahmedabad |
| topic | Chronic myeloid leukemia Gujarat cancer and research institute imatinib |
| url | http://www.ijmpo.org/article.asp?issn=0971-5851;year=2013;volume=34;issue=3;spage=189;epage=192;aulast=Shah |
| work_keys_str_mv | AT sandipashah thetreatmentofchronicmyeloidleukemiadatafromgujaratcancerandresearchinstituteahmedabad AT sandipashah treatmentofchronicmyeloidleukemiadatafromgujaratcancerandresearchinstituteahmedabad |